Exonate Taps Olav Hellebø as EXN407 Nears Phase 2b

• July 23, 2026

Stuart Therapeutics Spotlights Topical RP Program

At OIS Retina, Eric Schlumpf discussed the company’s collagen mimetic peptide platform for retinitis pigmentosa, now in preclinical development.

• by Eric Schlumpf

• July 15, 2026

• 2 min

Treating CME Without Reactivating Retinitis

Data from a retrospective Emory Eye Center series suggest most eyes with CME following infectious retinitis achieved resolution without disease reactivation, although prolonged treatment and close monitoring were often required.

• by Sruthi Arepalli, MD

• July 15, 2026

• 3 min

What Retina Specialists Have Learned From TRUCKEE

Carl J. Danzig, MD, reviews 4.5 years of real-world findings showing sustained anatomic improvements, longer treatment intervals, and a favorable safety profile with faricimab in neovascular AMD.

• by Carl Danzig, MD

• July 15, 2026

• 3 min